FSBA 2F5/5 has been shown to detect Protein Kinase C-?1 treated with FSBA.
| Inventor | Institute |
|---|---|
| Peter Parker | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| Cat. #: | 151231 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell biology;Tags and cell markers |
| Application: | IP ; WB ; ELISA ; IHC ; IF ; IP ; WB |
| Target: | Fluorylsulponylbenzoyladenosine (FSBA) |
| Clone: | FSBA 2F5/5 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | FSBA 2F5/5 has been shown to detect Protein Kinase C-?1 treated with FSBA. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | FSBA, a reactive ATP analogue, can be used to selectively label protein kinases, which may subsequently be detected and affinity purified using an anti-FSBA antibody. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Poyurovsky et al. 2003. Mol Cell. 12(4):875-87. PMID: 14580339. Nucleotide binding by the Mdm2 RING domain facilitates Arf-independent Mdm2 nucleolar localization. Parker et al. 1993. FEBS Lett. 334(3):347-50. PMID: 8243645. Antibodies to fluorylsulfonylbenzoyladenosine permit identification of protein kinases. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.